31st International Precision Med TRI-CON
日期:2024年3月26-28日
地点:美國, 加州, 聖地牙哥, Hilton San Diego Bayfront
Choose your language
Chinese
Japanese
Korean
English

TRI-CON 2024:30 多年来推动诊断与精准医学领域的创新与合作

三十年来,Precision Med TRI-CON 一直是诊断和精准医学界至关重要的国际会议场所。历年来均与数千名国际思想领袖一起讨论实施精准医学、生物标记和伴随诊断、基因组医学和精准健康的最新研究、技术、创新和商业模式;传染病的家庭诊断、护理点检测和分子诊断的创新和市场准入策略;液体活检和精准肿瘤学的先进诊断,包括多癌早期检测和微小残留疾病检测。而2024年的会议更将涵盖更快、更便宜的测序、人工智慧和数位工具以及空间生物学和单细胞多组学对推进精准医学的新兴影响。一起来到阳光明媚的圣地牙哥加入我们吧!TRI-CON将会安排各种现场交流和富有远见且发人深省的主题演讲等您所期待的各种会议活动。



2024年主讲人


J. Craig Venter

FIRESIDE CHAT: Artificial Intelligence Innovation for Precision Medicine
炉边谈话:精准医疗上的人工智慧创新

Eric Topol, MD, Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research

Interviewed by: Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University


Kari Stefansson

Kari Stefansson
CEO
deCODE genetics

Mara Aspinall

Mara Aspinall
Partner
Illumina Ventures

Anthony Sireci

Anthony Sireci
SVP, Diagnostics Development, Loxo Oncology
Eli Lilly

Atul Butte

Atul Butte
Chief Data Scientist
University of California Health

Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health

Esther Babady

Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Jeffrey Venstrom

Jeffrey Venstrom
CMO
GRAIL

Razelle Kurzrock

Razelle Kurzrock
CMO
Worldwide Innovative Network for Personalized Cancer Therapy

Jonathan Carlson

Jonathan Carlson
Managing Director
Microsoft Health Futures

Sonya Makhni

Sonya Makhni
Medical Director
Mayo Clinic Platform

Ezra Cohen

Ezra Cohen
CMO, Oncology
Tempus Labs

Howard Scher

Howard Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Jean-Francois Martini

Jean-Francois Martini
Diagnostics Lead, Oncology
Pfizer

Lourdes Barrera

Lourdes Barrera
Executive Director, Precision Medicine
Merck

Christopher Hartshorn

Christopher Hartshorn
Chief, Digital & Mobile Technologies
NCATS

Jai Pandey

Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi

George Vacek

George Vacek
Global Head, Genomics Alliances
NVIDIA

Larissa May

Larissa May
Director, Emergency Medicine Innovation
UC Davis Health

Peter Bach

Peter Bach
CMO
Delfi Diagnostics

Anne Beaubrun

Anne Beaubrun
VP, Global Health Economics & Outcomes
Cepheid

Yuan Luo

Yuan Luo
Chief AI Officer, Northwestern Univ.
Feinberg School of Medicine

John Mattison

John Mattison
Chief Medical Information Officer
Arsenal Capital Partners

Jennifer Quigley

Jennifer Quigley
Sr. Director, Precision Diagnostics
Novartis

Scott Penberthy

Scott Penberthy
Managing Director, Applied AI
Google Cloud

Sudhir Srivastava

Sudhir Srivastava
Chief, Cancer Biomarkers Research
NCI

Edward Abrahams

Edward Abrahams
President
Personalized Medicine Coalition

Jonathan Beer

Jonathan Beer
Sr. Director, Diagnostic Science
Bristol Myers Squibb

Jim Almas

Jim Almas
VP, Clinical Effectiveness
LabCorp

Stacey DaCosta Byfield

Stacey DaCosta Byfield
VP, Genomic Health Economics and Outcomes
Optum Labs

Larry Kessler

Larry Kessler
Co-Chair
MCED Consortium

Noah Zimmerman

Noah Zimmerman
VP, Translational Science
Tempus

Mark Gardner

Mark Gardner
SVP, Molecular Genomics
Quest Diagnostics

Lesley Northrop

Lesley Northrop
Chief Diagnostic Officer
Everly Health

Charles Chiu

Charles Chiu
Director, Clinical Microbiology Laboratory
UCSF

Christopher Conn

Christopher Conn
Director, Diagnostics Strategy
Amgen